Capital Management Paladin serves as Executive at CardioVascular BioTherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Capital Management Paladin has executed 3 insider transactions totaling $200.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on May 17, 2006 involved selling 10,000 shares valued at $62.5K.
Capital Management Paladin currently holds 1,470,000 shares of CardioVascular BioTherapeutics, Inc. (CVBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Management Paladin has been a net seller of CVBT stock. They have purchased $0 and sold $200.2K worth of shares.
Capital Management Paladin's most recent insider trade was on May 17, 2006, when they sold 10,000 shares at $6.25 per share.
Get notified when new Form 4 filings are submitted
| $5.95 |
| Discretionary |
| Apr 17, 2006 | CVBT | $78.2K | Sale | 10,000 | $7.82 | Discretionary |